Protirelin Acetate: Package Insert and Label Information

PROTIRELIN ACETATE- protirelin powder
Suzhou Qianyuan Biotechnology Co., Ltd.

Protirelin Acetate

image description
(click image for full-size original)
image description
(click image for full-size original)

PROTIRELIN ACETATE
protirelin acetate powder
Product Information
Product Type Item Code (Source) NDC:82773-003
Route of Administration NOT APPLICABLE DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PROTIRELIN (PROTIRELIN) PROTIRELIN 1 g in 1 g
Product Characteristics
Color white Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:82773-003-02 1 g in 1 VIAL None
2 NDC:82773-003-01 10 g in 1 JAR None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
bulk ingredient for animal drug compounding 11/30/2022
Labeler — Suzhou Qianyuan Biotechnology Co., Ltd. (554484460)
Establishment
Name Address ID/FEI Operations
Suzhou Qianyuan Biotechnology Co., Ltd. 554484460 api manufacture

Revised: 11/2022 Suzhou Qianyuan Biotechnology Co., Ltd.

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

https://druginserts.com/lib/other/meds/protirelin-acetate/

DrugInserts.com

Information Sections

RSS Feeds

About

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.